{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:46:18Z","timestamp":1787755578972,"version":"build-2784847793"},"reference-count":26,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.4103\/0972-5229.148631","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T09:13:22Z","timestamp":1420535602000},"page":"9-13","source":"Crossref","is-referenced-by-count":23,"title":["Therapeutic plasma exchange in the treatment of myasthenia gravis"],"prefix":"10.5005","volume":"19","author":[{"given":"Sonia","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","published-online":{"date-parts":[[2015]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Gilcher RO, Smith JW. Apheresis: Principles and technology of hemapheresis. In: Simon TI, Synder EL, Solheim C, Stowell P, Strauss G, Petrides M, editors. Rossi\u2032s Principles of Transfusion Medicine. USA: Wiley-Blackwell; 2009. p. 617-28.","DOI":"10.1002\/9781444303513.ch41"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: A systematic literature review. Neuroepidemiology 2010;34:171-83.","DOI":"10.1159\/000279334"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Strauss RG, Ciavarella D, Gilcher RO, Kasprisin DO, Kiprov DD, Klein HG, et al. An overview of current management. J Clin Apher 1993;8:189-94.","DOI":"10.1002\/jca.2920080402"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Assessment of plasmapheresis. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 1996;47:840-3.","DOI":"10.1212\/WNL.47.3.840"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Smith JW, Weinstein R, Hillyer KL, AABB Hemapheresis Committee, American Society for Apheresis. Therapeutic apheresis: A summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003;43:820-2.","DOI":"10.1046\/j.1537-2995.2003.00397.x"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 2002;CD002275.","DOI":"10.1002\/14651858.CD002275"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979;300:524-30.","DOI":"10.1056\/NEJM197903083001003"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Newsom-Davis J, Wilson SG, Vincent A, Ward CD. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979;1:464-8.","DOI":"10.1016\/S0140-6736(79)90823-7"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Heatwole C, Johnson N, Holloway R, Noyes K. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: An acute hospital cost comparison study. J Clin Neuromuscul Dis 2011;13:85-94.","DOI":"10.1097\/CND.0b013e31822c34dd"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Zinman L, Ng E, Bril V. IV immunoglobulin in patients with myasthenia gravis: A randomized controlled trial. Neurology 2007;68:837-41.","DOI":"10.1212\/01.wnl.0000256698.69121.45"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Murthy JM, Meena AK, Chowdary GV, Naryanan JT. Myasthenic crisis: Clinical features, complications and mortality. Neurol India 2005;53:37-40.","DOI":"10.4103\/0028-3886.15050"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol 1997;41:789-96.","DOI":"10.1002\/ana.410410615"},{"key":"ref=13","unstructured":"13. Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans 1990;36:M597-9."},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Pinching AJ, Peters DK. Remission of myasthenia gravis following plasma-exchange. Lancet 1976;2:1373-6.","DOI":"10.1016\/S0140-6736(76)91917-6"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 2012;12:CD002277.","DOI":"10.1002\/14651858.CD002277.pub4"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Yeh JH, Chiu HC, Therapeutic Apheresis Registry Group in Taiwan. Therapeutic apheresis in Taiwan. Ther Apher 2001;5:513-6.","DOI":"10.1046\/j.1526-0968.2001.00353.x"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Carandina-Maffeis R, Nucci A, Marques JF Jr, Roveri EG, Pfeilsticker BH, Garibaldi SG, et al. Plasmapheresis in the treatment of myasthenia gravis: Retrospective study of 26 patients. Arq Neuropsiquiatr 2004;62:391-5.","DOI":"10.1590\/S0004-282X2004000300003"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"18. Werneck LC, Scola RH, Germiniani FM, Comerlato EA, Cunha FM. Myasthenic crisis: Report of 24 cases. Arq Neuropsiquiatr 2002;60:519-26.","DOI":"10.1590\/S0004-282X2002000400001"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"19. Rodnitzky RL, Bosch EP. Chronic long-interval plasma exchange in myasthenia gravis. Arch Neurol 1984;41:715-7.","DOI":"10.1001\/archneur.1984.04050180037013"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"20. Madore F. Plasmapheresis. Technical aspects and indications. Crit Care Clin 2002;18:375-92.","DOI":"10.1016\/S0749-0704(01)00010-0"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"21. Kiprov DD, Golden P, Rohe R, Smith S, Hofmann J, Hunnicutt J. Adverse reactions associated with mobile therapeutic apheresis: Analysis of 17,940 procedures. J Clin Apher 2001;16:130-3.","DOI":"10.1002\/jca.1024"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"22. Kaplan AA. Therapeutic plasma exchange: A technical and operational review. J Clin Apher 2013;28:3-10.","DOI":"10.1002\/jca.21257"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"23. Korach JM, Petitpas D, Paris B, Bourgeade F, Passerat V, Berger P, et al. Plasma exchange in France: Epidemiology 2001. Transfus Apher Sci 2003;29:153-7.","DOI":"10.1016\/S1473-0502(03)00120-4"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"24. Seggia JC, Abreu P, Takatani M. Plasmapheresis as preparatory method for thymectomy in myasthenia gravis. Arq Neuropsiquiatr 1995;53:411-5.","DOI":"10.1590\/S0004-282X1995000300007"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"25. Lazo-Langner A, Espinosa-Poblano I, Tirado-C\u00e1rdenas N, Ram\u00edrez-Arvizu P, L\u00f3pez-Salmor\u00e1n J, Pe\u00f1aloza-Ram\u00edrez P, et al. Therapeutic plasma exchange in Mexico: Experience from a single institution. Am J Hematol 2002;70:16-21.","DOI":"10.1002\/ajh.10081"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"26. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue. J Clin Apher 2013;28:145-284.","DOI":"10.1002\/jca.21276"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/0972-5229.148631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T10:22:51Z","timestamp":1717669371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/0972-5229.148631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015]]}},"alternative-id":["10.4103\/0972-5229.148631"],"URL":"https:\/\/doi.org\/10.4103\/0972-5229.148631","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}